Nigeria - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Nigeria Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 25% year on year. In 2019, the country was ranked number 24 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 2,433 Cases. Nigeria is overtaken by Myanmar, which was number 23 at 3,205 Cases and is followed by Uzbekistan at 2,405 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 2,433.00 |
| 2018 | 2,268.00 |
| 2017 | 2,286.00 |
| 2016 | 1,686.00 |
| 2015 | 1,241.00 |
How does Nigeria rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 21 |
#21
Republic of the Congo
|
3,514 | 2019 | +5,660.7 % | +171.1 % | View data | |
| 24 |
#24
Nigeria
|
2,433 | 2019 | +7.3 % | +25.0 % | View data | |
| 25 |
#25
Uzbekistan
|
2,405 | 2019 | +2.4 % | -8.9 % | View data | |